Prof. Markel is a Clinician and basic researcher, he is the Chief Scientist of the Ella Lemelbaum Institute for Immuno-Oncology, Sheba medical center and Associate Professor of Immunology (Tel Aviv University). Prof. Markel is an expert in Immuno-Oncology with broad experience in integrative platforms, including genetics, cell biology, animal models and immunology. He is the author of 88 scientific peer-reviewed articles and the inventor of 12 US patent and applicant of 11 other patent applications in various fields. Prof. Markel was the CSO and scientific founder of cCAM Biotherapeutics.
